Published 4 days ago • loading... • Updated 3 days ago

AI-powered model improves prediction of bladder cancer treatment outcomes

Summary by News Medical

Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more effective model for predicting how patients with muscle-invasive bladder cancer will respond to chemotherapy.

9 Articles

All

Left

Center

Right

Science Daily

Reposted by

Medical Xpress

Center

AI meets oncology: New model personalizes bladder cancer treatment

Leveraging the power of AI and machine learning technologies, researchers developed a more effective model for predicting how patients with muscle-invasive bladder cancer will respond to chemotherapy. The model harnesses whole-slide tumor imaging data and gene expression analyses in a way that outperforms previous models using a single data type.

3 days ago·United States

Read Full Article

Nature

Center

Predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer via interpretable multimodal deep learning

Building accurate prediction models and identifying predictive biomarkers for treatment response in Muscle-Invasive Bladder Cancer (MIBC) are essential for improving patient survival but remain challenging due to tumor heterogeneity, despite numerous related studies. To address this unmet need, we developed an interpretable Graph-based Multimodal Late Fusion (GMLF) deep learning framework. Integrating histopathology and cell type data from stand…

3 days ago·United Kingdom

Read Full Article

News Medical

Center

AI-powered model improves prediction of bladder cancer treatment outcomes

4 days ago·United States

Read Full Article

quantumzeitgeist.com

AI-Powered Model In Oncology: Personalized Bladder Cancer Treatment At Weill Cornell Medicine Revolutionizes Chemotherapy Prediction

Researchers at Weill Cornell Medicine developed an AI-driven model integrating whole-slide tumor imaging and gene expression data to predict chemotherapy responses in bladder cancer patients more accurately than previous single-data-type models, enabling personalized treatment decisions and potentially sparing some from bladder removal.

3 days ago

Read Full Article

cancernetwork.com

FDA Approves Adjuvant Durvalumab/Chemo in Muscle-Invasive Bladder Cancer

Results from the phase 3 NIAGARA trial led to the approval of adjuvant durvalumab/chemotherapy for patients with muscle-invasive bladder cancer after radical cystectomy.

3 days ago

Read Full Article

The Cancer Letter

Weill Cancer Hub East to investigate connections between metabolism and anti-tumor immunity Weill Cornell, Rockefeller, Princeton and the Ludwig Institute for Cancer Research showcase the power of collaboration - The Cancer Letter

The immune system can be a powerful tool to control cancer. Immune cells within our body detect cancer cells and release payloads that kill them. Transformative science in the last decade has led to the development of therapies that enhance the ability of our immune cells to carry out this function. These therapies, including checkpoint blockade and CAR-T cells, have been lifesaving for many patients that before had untreatable cancer. But, sadl…

4 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year